RATIONALE AND OBJECTIVES. Because new diagnostic tests become availabl
e rapidly, the authors determined a need for proper assessment of test
s before their implementation in clinical practice, Three factors are
of pivotal importance: the selection of the proper study population, t
he determination of the diagnostic power including its related statist
ical analysis, and the relation of the new test to current diagnostic
tools, Patients suspected of having a disease are those who would bene
fit from the application of a new test, Therefore, only those patients
need be involved in the assessment study. METHODS. Summary measures o
f diagnostic power other than sensitivity and specificity are advocate
d because these conventional measures depend on cutoff points and are
susceptible to selection bias, The relation between the new test and e
xisting diagnostic tools must be established to determine if the new t
est contributes to the diagnostic process. RESULTS AND CONCLUSION. TO
avoid waste of effort and money, the authors suggest a prudent assessm
ent approach in phases, Whereas the initial challenge consists of sele
ction of an adequate patient population, subsequently all determinants
of disease (signs, symptoms, comorbidity, and other diagnostic factor
s) and factors influencing the decision to use a test (patient burden
and cost) are considered,